Goldman Sachs, Market
Expectations of a banner year in dealmaking have not yet materialized due to worries about inflation and uncertainties over U ...
12h
Fintel on MSNGoldman Sachs Initiates Coverage of Summit Therapeutics (SMMT) with Buy RecommendationFintel reports that on February 28, 2025, Goldman Sachs initiated coverage of Summit Therapeutics (NasdaqGM:SMMT) with a Buy ...
Palantir Technologies (PLTR) has been among the best-performing stocks over the past 12 months, driven by improving earnings, ...
Goldman Sachs raised the firm’s price target on DigitalOcean (DOCN) to $46 from $44 and keeps a Buy rating on the shares. The company reported a ...
Dip buyers are missing in action as the narrative for stocks is quickly souring due to the negative news flow on trade.
The smart money is turning bearish on stocks. Discover the Best Stocks and Maximize Your Portfolio: See what stocks are receiving Strong Buy ...
Global hedge funds sold more stocks than they bought by the largest amount in a year, mainly driven by their bets that stocks ...
1d
Zacks.com on MSNInvestors Heavily Search The Goldman Sachs Group, Inc. (GS): Here is What You Need to KnowGoldman Sachs (GS) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...
Goldman Sachs raised the firm’s price target on General Motors (GM) to $73 from $72 and keeps a Buy rating on the shares. The firm cites the ...
Goldman Sachs analyst Richard Law lowered the firm’s price target on Rocket Pharmaceuticals (RCKT) to $15 from $29 and keeps a Neutral rating on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results